'Complete response' presentation slideshows

1.48k views • 119 slides

Sorafenib in Advanced Hepatocellular Carcinoma

1.47k views • 108 slides

Ovarian borderline tumors

Ovarian borderline tumors. Nadeem R. Abu-Rustum, MD Memorial Sloan-Kettering Cancer Center. Key Points. Serous LMP Mucinous LMP Favorable outcome Fertility consequences. Borderline tumors. Synonyms: Tumor of borderline malignancy Borderline tumor (BT)

1.83k views • 65 slides

Victor A Marcial- Vega,MD www.marcialvegamd.com marcialvegamd@aol.com April 2013

The Use of Oral, Topical and Intravenous Detoxification Strategies in the Management of Cancer and Other Diseases. Victor A Marcial- Vega,MD www.marcialvegamd.com marcialvegamd@aol.com April 2013. Patient Population. 210 Patients in Puerto Rico Age Range 10-88 years old

646 views • 55 slides

Update on Novel Combinations for Relapsed/Refractory Disease: Approved Drugs

Update on Novel Combinations for Relapsed/Refractory Disease: Approved Drugs. James R. Berenson, MD Medical & Scientific Director Institute for Myeloma & Bone Cancer Research Los Angeles, CA. Treatment Choices. Anthracyclines Doxorubicin PLD . Thal. Carfilzomib. Bortezomib.

543 views • 39 slides

Business Process Modeling and BPMN Training

Business Process Modeling and BPMN Training. Business Process Modeling An Introduction Getting Started BPMN Overview Graphical Elements Diagram views with BPMN. Agenda. Business Process Modeling.

1.11k views • 37 slides

SEX CORD-STROMAL TUMORS

SEX CORD-STROMAL TUMORS. Dr.Aytekin Alt?nta?. ADANA. Granulosa cell tumor Adult Juvenile Thecoma-fibroma Thecoma Fibroma,sarkoma Sclerosing stromal tumor. SEX CORD-STROMAL TUMORS CLASSIFICATION. 1-GRANULOSA-STROMAL. 2-SERTOLI-STROMAL. 3-STEROID CELL. Sertoli cell Leydig cell

2.03k views • 31 slides

Novel Agents for Lung Cancer

Novel Agents for Lung Cancer. Suresh S. Ramalingam, MD Associate Professor Director, Division of Medical Oncology Emory University Winship Cancer Institute. Anaplastic Lymphoma Kinase (ALK).

525 views • 30 slides

Chemotherapeutic Treatment Options for Triple Negative Breast Cancer

Chemotherapeutic Treatment Options for Triple Negative Breast Cancer. Lauren Barney April 17, 2013. Breast Cancer Subtypes. Luminal A. Luminal B. Claudin -Low. Basal. HER2-enriched. ER: estrogen receptor PR: progesterone receptor HER2: human epidermal growth factor receptor 2.

779 views • 30 slides

MEASURING CLINICAL EFFICACY IN PHASE II TRIALS

MEASURING CLINICAL EFFICACY IN PHASE II TRIALS. Response: Karnofsky, WHO, RECIST Event rate: progression free/survival Time to event: progression/survival Functional imaging Mutational analysis-biomarkers. Endpoints Used in SWOG Phase II Trials.

442 views • 24 slides

1 University of Chicago Medical Center, Chicago IL 2 US Oncology Research, Tyler, TX

A Placebo-Controlled, Randomized Phase 2 Study of Conatumumab (C) or AMG 479 (A) or Placebo (P) + Gemcitabine (G) in Patients (pts) With Metastatic Pancreatic Cancer ( mPC ).

460 views • 24 slides

ALM CAO

AGITG. ALM CAO. Peri -operative FOLFOX4 chemotherapy and surgery for resectable liver metastases from colorectal cancer Long-term survival results of the EORTC Intergroup phase III study 40983.

488 views • 23 slides

Transitioning to the Common Core: MDTP Written Response Items

319 views • 19 slides

Learning Strategies and Coaching: Pathways to Self- Determination

Learning Strategies and Coaching: Pathways to Self- Determination. David R. Parker, Ph.D. (CRG) Postsecondary Disability Specialist/ADD&Life Coach www.childrensresourcegroup.com (317) 575-9111 ext. 146. Overview of Strand . Day 1: Strategy Instruction Important outcomes

280 views • 16 slides

382 views • 16 slides

Biological pleurodesis with powder collagen at malignant pleural effusion

Biological pleurodesis with powder collagen at malignant pleural effusion. A.Akopov, V.Egorov, V.Varlamov Research Institute of Pulmonology, Saint-Petersburg, Russian Federation. Objective. Malignant pleural effusions are a common medical problem.

395 views • 15 slides

Suzanne Wolden, Elizabeth Lyden, Carola Arndt, Douglas Hawkins,

282 views • 13 slides

English III

224 views • 9 slides

385 views • 6 slides

Tuesday, March 4 th

186 views • 6 slides